US Patent Issued to Arog Pharmaceuticals on June 23 for "Crenolanib for treating FLT3 mutated proliferative disorders associated mutations" (Texas Inventor)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,706, issued on June 23, was assigned to Arog Pharmaceuticals Inc. (Plano, Texas).

"Crenolanib for treating FLT3 mutated proliferative disorders associated mutations" was invented by Vinay K. Jain (Dallas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes methods for treating a human patient with Crenolanib, wherein the human patient is suffering from a FLT3 mutated leukemia, the method comprising: determining that the human patient has a poor prognosis by: obtaining or having obtained a leukemia biological sample and performing or having performed a genotyping assay on the biological sample to determine that the human pati...